04 May 2026 Healthcare Stocks International Stocks Eli Lilly (NYSE:LLY): This US$900bn company is set to beat Novo Nordisk & Ozempic For investors who missed the run in Novo Nordisk shares, Eli Lilly (NYSE:LLY) appeared to be the next best thing. And perhaps those who bought into Eli Lilly would have… ByNick Sundich